Literature DB >> 8671855

Frequency of adynamic bone disease and aluminum storage in Italian uraemic patients--retrospective analysis of 1429 iliac crest biopsies.

P Ballanti1, B M Wedard, E Bonucci.   

Abstract

BACKGROUND: Adynamic bone disease was initially attributed too aluminum intoxication in association with low circulating levels of parathyroid hormone. More recently adynamic bone disease has been described even in the absence of aluminum intoxication. PURPOSE OF THE STUDY: It was the purpose of this retrospective analysis of 1429 iliac crest biopsies sent to our laboratory from 1985 to 1994 by 41 Italian nephrology and dialysis centres to assess the frequency of adynamic bone disease and aluminum accumulation.
METHODS: Adynamic bone disease was diagnosed by histological and histodynamic (tetracycline labelling) analysis, on the basis of predetermined criteria. Aluminum accumulation was assessed by aluminon histochemical staining.
RESULTS: The frequency of adynamic bone disease was fairly constant at approximately 15% from 1985 to 1994. In contrast, aluminum accumulation, defined as positive aluminon histochemical staining, decreased during the same period from 36% to 4%.
CONCLUSIONS: Our data clearly show a dissociation of the incidence of adynamic bone disease and aluminium accumulation in bone. At least today, given the low prevalence of aluminium intoxication, factors other than aluminium are the main cause of adynamic bone disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8671855     DOI: 10.1093/oxfordjournals.ndt.a027356

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  6 in total

1.  Biochemical indices of renal osteodystrophy in dialysis patients on the island of Malta.

Authors:  Ian Galea; Emanuel Farrugia
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

Review 2.  Update on the role of bone biopsy in the management of patients with CKD-MBD.

Authors:  P Evenepoel; G J S Behets; M R Laurent; P C D'Haese
Journal:  J Nephrol       Date:  2017-08-22       Impact factor: 3.902

Review 3.  Vitamin D in patients with chronic kidney disease: a position statement of the Working Group "Trace Elements and Mineral Metabolism" of the Italian Society of Nephrology.

Authors:  Luigi Francesco Morrone; Pergiorgio Bolasco; Corrado Camerini; Giuseppe Cianciolo; Adamasco Cupisti; Andrea Galassi; Sandro Mazzaferro; Domenico Russo; Luigi Russo; Mario Cozzolino
Journal:  J Nephrol       Date:  2016-04-09       Impact factor: 3.902

4.  Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines.

Authors:  G Klaus; A Watson; A Edefonti; M Fischbach; K Rönnholm; F Schaefer; E Simkova; C J Stefanidis; V Strazdins; J Vande Walle; C Schröder; A Zurowska; M Ekim
Journal:  Pediatr Nephrol       Date:  2005-10-25       Impact factor: 3.714

5.  Adynamic bone disease.

Authors:  Ana Paula Santana Gueiros; Rodrigo Azevedo de Oliveira; Aluizio Barbosa Carvalho
Journal:  J Bras Nefrol       Date:  2021-12-03

6.  Renal osteodystrophy and clinical outcomes: data from the Brazilian Registry of Bone Biopsies - REBRABO.

Authors:  Cinthia Esbrile Moraes Carbonara; Luciene Machado Dos Reis; Kélcia Rosana da Silva Quadros; Noemi Angelica Vieira Roza; Rafael Sano; Aluizio Barbosa Carvalho; Vanda Jorgetti; Rodrigo Bueno de Oliveira
Journal:  J Bras Nefrol       Date:  2020-01-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.